» Articles » PMID: 37641548

Interaction Between Cerebral Small Vessel Disease, Blood Pressure, and Remote Ischemic Lesions in Acute Spontaneous Intracerebral Hemorrhage

Overview
Journal Eur Stroke J
Date 2023 Aug 29
PMID 37641548
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Acute blood pressure (BP) reduction is the first-line treatment for acute spontaneous intracerebral hemorrhage (ICH); however, recent research suggests that intensive BP reduction along with cerebral small vessel disease (cSVD) is a risk factor for remote DWI lesions (RDWILs). We aimed to delineate the interplay between cSVD and BP reduction therapy on the risk of RDWILs.

Methods: We enrolled 303 patients who underwent brain magnetic resonance imaging within 7 days after acute spontaneous ICH. RDWILs were categorized as occurring in borderzone (BZ) or non-BZ areas. We examined the effect of cSVD, acute BP reduction, and their interaction on RDWILs.

Results: RDWILs were observed in 34 (11%) patients (59.8 ± 10.3-years-old, 24% male). RDWILs were associated with a larger acute weighted average mean arterial pressure (MAP) reduction in the initial 24 h after ICH onset and a higher total cerebral microbleed (CMB) count. Intensive MAP changes (odds ratio (OR) per 10 mmHg 1.76, 95% confidence interval (CI) 1.03-3.20), total CMBs burden (OR per 10 CMBs 1.21, 95% CI 1.08-1.39), and presence of lobar CMBs (OR 7.33, 95% CI 1.59-55.6) were risk factors for RDWILs at BZ, but not at non-BZ. Furthermore, a significant interaction was observed between lobar CMBs and MAP reduction on increased risk of RDWILs at BZ ( = 0.030).

Conclusion: cSVD modulates the effect of acute BP reduction on the risk of RDWILs. Patients with extensive microangiopathy have a higher risk of developing cerebral ischemic changes in BZ during unstable hemodynamic status.

Citing Articles

Neuroprotection on ischemic brain injury by Mg/H released from endovascular Mg implant.

Zhang Y, Zhang H, Jiang M, Cao X, Ge X, Song B Bioact Mater. 2024; 42:124-139.

PMID: 39280580 PMC: 11402188. DOI: 10.1016/j.bioactmat.2024.08.019.

References
1.
Tsai H, Pasi M, Tsai L, Chen Y, Lee B, Tang S . Microangiopathy underlying mixed-location intracerebral hemorrhages/microbleeds: A PiB-PET study. Neurology. 2019; 92(8):e774-e781. PMC: 6396971. DOI: 10.1212/WNL.0000000000006953. View

2.
Kidwell C, Rosand J, Norato G, Dixon S, Worrall B, James M . Ischemic lesions, blood pressure dysregulation, and poor outcomes in intracerebral hemorrhage. Neurology. 2017; 88(8):782-788. PMC: 5344081. DOI: 10.1212/WNL.0000000000003630. View

3.
Hemphill 3rd J, Greenberg S, Anderson C, Becker K, Bendok B, Cushman M . Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2015; 46(7):2032-60. DOI: 10.1161/STR.0000000000000069. View

4.
Boulanger M, Schneckenburger R, Join-Lambert C, Werring D, Wilson D, Hodel J . Diffusion-Weighted Imaging Hyperintensities in Subtypes of Acute Intracerebral Hemorrhage: Meta-Analysis. Stroke. 2018; 50(1):135-142. DOI: 10.1161/STROKEAHA.118.021407. View

5.
Mangla R, Kolar B, Almast J, Ekholm S . Border zone infarcts: pathophysiologic and imaging characteristics. Radiographics. 2011; 31(5):1201-14. DOI: 10.1148/rg.315105014. View